Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Giovanni Martinelli Simona Soverini Jerald P Radich Daniela Cilloni Richard J Woodman Fabrizio Pane Deborah L. White Giuseppe Saglio |
| Publication date | December 29, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |